(Q34421129)

2 August 2017

title

Progress in the use of biological assays during the development of biotechnology products (English)

1 reference

2 August 2017

0 references

Mire-Sluis AR

1

1 reference

2 August 2017

publication date

1 September 2001

1 reference

2 August 2017

published in

Pharmaceutical Research

1 reference

2 August 2017

volume

18

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

1239-1246

1 reference

Evaluation of assay designs for assays using microtitre plates: results of a study of in vitro bioassays and immunoassays for tumour necrosis factor (TNF).

2 August 2017

cites work

1 reference

12 December 2020

Use of a dual firefly and Renilla luciferase reporter gene assay to simultaneously determine drug selectivity at human corticotrophin releasing hormone 1 and 2 receptors.

1 reference

12 December 2020

BIACORE: an affinity biosensor system for characterization of biomolecular interactions

1 reference

12 December 2020

Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines

1 reference

12 December 2020

Bioassays of gonadotropins

1 reference

12 December 2020

A fully human antibody neutralising biologically active human TGFbeta2 for use in therapy

1 reference

12 December 2020

Quality considerations for recombinant DNA-derived biological therapeutic products: a control perspective on cytokines

1 reference

12 December 2020

WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents.

1 reference

12 December 2020

Control and statistical analysis of in vitro reporter gene assays.

1 reference

12 December 2020

Challenges with current technology for the detection, measurement and characterization of antibodies against biological therapeutics

1 reference

12 December 2020

Luciferase reporter gene assay in mammalian cells

1 reference

12 December 2020

Quantitative analysis of gene expression with an improved green fluorescent protein

1 reference

12 December 2020

Biological assays: their role in the development and quality control of recombinant biological medicinal products

1 reference

12 December 2020

Applications for the new electrochemiluminescent (ECL) and biosensor technologies

1 reference

12 December 2020

Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay

1 reference

12 December 2020

The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators.

1 reference

12 December 2020

ELISA methods for the analysis of antibody responses induced in multiple sclerosis patients treated with recombinant interferon-beta

1 reference

12 December 2020

Cytokines--protein structure and biological activity: a complex relationship with implications for biological assays and standardization

1 reference

12 December 2020

Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays

1 reference

12 December 2020

Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5

1 reference

12 December 2020

Development and application of surface plasmon resonance-based biosensors for the detection of cell-ligand interactions

1 reference

12 December 2020

Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance.

1 reference

12 December 2020

A sensitive and versatile bioassay for ligands that signal through receptor clustering

1 reference

12 December 2020

Validation of a rat pheochromocytoma (PC12)-based cell survival assay for determining biological potency of recombinant human nerve growth factor.

1 reference

12 December 2020

The development of non-animal-based bioassays for cytokines and growth factors.

1 reference

12 December 2020

The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.

1 reference

12 December 2020

International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS

1 reference

12 December 2020

Correct evaluation of reporter assays in different cell lines by direct determination of the introduced plasmid amount.

1 reference

12 December 2020

Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1013067424248

1 reference

2 August 2017

1 reference